AMRUTANJAN.NS

Amrutanjan Health Care Limited AMRUTANJAN.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode AMRUTANJAN.NS WINDLAS.NS NOVARTIND.BO WINDLAS.BO BLISSGVS.BO BLISSGVS.NS HESTERBIO.BO HESTERBIO.NS SYNCOMF.BO SYNCOMF.NS
6M 9.58 % -7.16 % 5.50 % -7.04 % 24.95 % 25.55 % -13.40 % -13.17 % -2.23 % -2.17 %
YTD -0.43 % -11.03 % -5.33 % -11.16 % -14.11 % -13.79 % -29.52 % -29.53 % -19.83 % -19.93 %
1Y -0.64 % -3.59 % -18.18 % -3.71 % 40.36 % 40.47 % -23.77 % -24.28 % -9.01 % -8.86 %
3Y -3.76 % 318.50 % 26.10 % 310.62 % 105.53 % 106.35 % -15.19 % -15.49 % 49.02 % 105.80 %
5Y 74.91 % 128.13 % 38.22 % 128.18 % -11.36 % -11.48 % -5.90 % -6.06 % 49.02 % 105.80 %
10Y 233.12 % 128.13 % -6.46 % 128.18 % -14.37 % -14.06 % 170.37 % 170.57 % 49.02 % 105.80 %
From the beginning 1 582.38 % 128.13 % 273.93 % 128.18 % 59 830.83 % 275.02 % 45 796.46 % 264.76 % 49.02 % 105.80 %

Dividend

Amrutanjan Health Care Limited

Windlas Biotech Limited

Novartis India Limited

Windlas Biotech Limited

Bliss GVS Pharma Limited

Bliss GVS Pharma Limited

Hester Biosciences Limited

Hester Biosciences Limited

Syncom Formulations (India) Limited

Syncom Formulations (India) Limited